SHAPIRO ROBERT N - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 116 filers reported holding CLOVIS ONCOLOGY INC in Q3 2013. The put-call ratio across all filers is 1.11 and the average weighting 0.3%.

Quarter-by-quarter ownership
SHAPIRO ROBERT N ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q4 2014$131,000
+23.6%
2,3330.0%0.03%
+30.0%
Q3 2014$106,000
+9.3%
2,3330.0%0.02%
+11.1%
Q2 2014$97,000
-40.1%
2,3330.0%0.02%
-40.0%
Q1 2014$162,000
+14.9%
2,3330.0%0.03%
+20.0%
Q4 2013$141,000
-0.7%
2,3330.0%0.02%0.0%
Q3 2013$142,0002,3330.02%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2013
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$45,630,648,00043.63%
EcoR1 Capital, LLC 384,348$21,523,00010.89%
Palo Alto Investors LP 2,102,857$117,760,0006.91%
NEA Management Company, LLC 2,279,781$127,668,0006.19%
Redmile Group, LLC 721,632$40,411,0004.40%
Opaleye Management Inc. 140,000$7,840,0003.96%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 790,555$44,271,0002.63%
SUFFOLK CAPITAL MANAGEMENT LLC 339,327$19,002,0002.31%
PFM Health Sciences, LP 1,725,126$96,607,0002.26%
HARBOURVEST PARTNERS LLC 51,037$2,858,0001.50%
View complete list of CLOVIS ONCOLOGY INC shareholders